 | Stephen J. Tulipano Sells 30,000 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) Stock
americanbankingnews.com - February 24 at 9:14 PM |
 | Stoke Therapeutics Inc (STOK) CFO Stephen J Tulipano Sold $1.8 million of Shares
finance.yahoo.com - February 24 at 8:46 PM |
| Insider Selling: Stoke Therapeutics, Inc. (NASDAQ:STOK) Director Sells 10,000 Shares of Stock
americanbankingnews.com - February 23 at 6:42 PM |
| FY2020 Earnings Estimate for Stoke Therapeutics, Inc. (NASDAQ:STOK) Issued By Wedbush
americanbankingnews.com - February 12 at 6:34 AM |
| Equities Analysts Set Expectations for Stoke Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:STOK)
americanbankingnews.com - February 11 at 9:29 AM |
| Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - February 11 at 5:06 AM |
| Wedbush Lowers Stoke Therapeutics (NASDAQ:STOK) to Neutral
americanbankingnews.com - February 10 at 7:48 AM |
| Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 5.8%
americanbankingnews.com - February 8 at 9:38 PM |
| Stoke Therapeutics (NASDAQ:STOK) Trading 6.4% Higher
americanbankingnews.com - February 2 at 7:38 PM |
| Mersana Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 9:19 AM |
|
| Mersana Therapeutics Announces Corporate and Pipeline Updates and 2021 Goals and Anticipated Milestones
finance.yahoo.com - January 5 at 1:13 PM |
 | MRSN May 2021 17.500 put
uk.finance.yahoo.com - January 1 at 3:35 AM |
| MRSN Jan 2021 12.500 put
uk.finance.yahoo.com - December 31 at 10:08 PM |
| MRSN Jan 2021 22.500 put
uk.finance.yahoo.com - December 31 at 10:08 PM |
| STOK Jan 2021 50.000 put
au.finance.yahoo.com - December 29 at 12:38 AM |
| STOK Feb 2021 65.000 call
au.finance.yahoo.com - December 28 at 2:33 PM |
| STOK Jan 2021 30.000 call
au.finance.yahoo.com - December 27 at 10:16 PM |
| STOK Feb 2021 20.000 call
au.finance.yahoo.com - December 27 at 10:16 PM |
| Health Check: How Prudently Does Mersana Therapeutics (NASDAQ:MRSN) Use Debt?
finance.yahoo.com - December 25 at 12:35 PM |
| Mersana Therapeutics to Host Virtual Analyst and Investor Event
finance.yahoo.com - December 17 at 9:46 AM |
| Stoke Therapeutics Announces Presentations Related to the Company’s Work to Advance STK-001, the First Potential New Medicine to Target the Underlying Cause of Dravet Syndrome at the American Epilepsy Society (AES) 2020 Annual Meeting
finance.yahoo.com - December 4 at 1:55 PM |
| Mersana Therapeutics Appoints Arvin Yang, M.D., Ph.D. as Senior Vice President and Chief Medical Officer
finance.yahoo.com - November 30 at 2:55 PM |
| Stoke Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - November 24 at 4:59 PM |
 | Stoke Therapeutics prices $97.5M public offering
seekingalpha.com - November 20 at 3:09 AM |
| Stoke Therapeutics -2.7% AH, proposes public offering
seekingalpha.com - November 18 at 8:53 PM |
 | STOK Crosses Above Average Analyst Target
nasdaq.com - November 12 at 9:59 PM |
 | Stoke Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
businesswire.com - November 9 at 7:40 AM |
| Have Insiders Been Buying Mersana Therapeutics, Inc. (NASDAQ:MRSN) Shares?
finance.yahoo.com - November 5 at 12:29 PM |
 | ‘The aim is to get Stoke City back to the Premier League’ – Stand-in captain Mikel
msn.com - October 24 at 9:12 AM |
| Mersana Therapeutics to Present Preclinical Data from Immunosynthen STING-Agonist ADC Platform at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
finance.yahoo.com - October 20 at 7:37 AM |
|
| SRNE Oct 2020 20.000 call
finance.yahoo.com - October 17 at 5:39 PM |
| Stoke Therapeutics advances STK-001 dosing in early-stage study in a rare form of childhood epilepsy
seekingalpha.com - October 7 at 8:23 AM |
| Why Mersana Therapeutics' (NASDAQ:MRSN) CEO Pay Matters
finance.yahoo.com - September 21 at 1:43 PM |
| Stoke Therapeutics (NASDAQ:STOK) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - September 15 at 1:23 PM |
| Mersana Therapeutics to Present Updated Interim Data from the Ovarian Cancer Cohort of the XMT-1536 Phase 1 Expansion Study at the 2020 ESMO Virtual Congress
finance.yahoo.com - September 10 at 10:06 AM |
| Dean Ashton on Stoke interest of 2009: I was in no fit state to move anywhere
msn.com - September 8 at 6:40 PM |
| Three paintings set to be put in Stoke STUDENT FLAT are worth £20,000
msn.com - September 5 at 9:22 AM |
| What does 'can they do it on a cold rainy night in Stoke' mean? Messi phrase explained
msn.com - September 5 at 4:21 AM |
| Stoke's STK-001 preclinical data published in a science journal
seekingalpha.com - August 26 at 6:08 PM |
| Stoke's STK-001 shows encouraging action in preclinical study
seekingalpha.com - August 26 at 6:08 PM |
| Stoke Therapeutics EPS misses by $0.04
seekingalpha.com - August 10 at 10:26 AM |
 | Stoke Therapeutics Inc
reuters.com - August 9 at 8:29 AM |
 | Stoke Therapeutics to Present at Upcoming Investor Conferences in August
benzinga.com - August 4 at 1:28 PM |
| BRIEF-Stoke Therapeutics Reports Q1 Financial Results
www.reuters.com - May 15 at 10:45 PM |
 | Stoke Therapeutics Inc.
www.barrons.com - May 15 at 5:45 PM |
| Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
finance.yahoo.com - May 15 at 7:44 AM |
| Stoke Therapeutics Presents Preclinical Data That Demonstrate In-Vitro and In-Vivo Target Engagement and Protein Upregulation in OPA1 Protein Deficiency, the Primary Cause of the Most Common Inherited Optic Nerve Disorder
finance.yahoo.com - May 12 at 2:26 PM |
| Stoke Therapeutics Reports Full Year 2019 Financial Results and Provides Business Updates
finance.yahoo.com - March 23 at 1:00 PM |
| Stoke Therapeutics to Present at 40th Annual Cowen Health Care Conference
finance.yahoo.com - February 24 at 9:31 AM |
| Slaven Bilic handed big West Brom boost ahead of Stoke City clash
www.msn.com - January 18 at 12:31 PM |
